lobbying_activities: 1560286

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1560286	70215a43-5d6e-4e3a-ad2c-8f6af03d9485	Q2	BROWN RUDNICK LLP	287895	HOSPIRA, INC.	2014	second_quarter	PHA	Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products)	HOUSE OF REPRESENTATIVES,SENATE,White House Office	50000		0	0	2014-07-18T12:54:42.920000-04:00